When organizations decide to include fentanyl in a drug testing program, the next question is often: How is fentanyl actually detected?
Fentanyl is a synthetic opioid, which means it may require specific screening designed to identify it. Unlike some traditional substances that have long been included in standard drug testing panels, fentanyl is often added through dedicated test lines or expanded panel configurations.
Today, fentanyl screening is available in several testing formats, including urine and oral fluid testing. The appropriate testing method depends on the organization's objectives, collection process, and overall program design.
Like other screening methods, fentanyl tests are designed to identify the presence of targeted substances at established cutoff levels. If a screening result is non-negative, organizations may choose to follow established procedures for confirmatory laboratory testing when appropriate.
Understanding the difference between a standard drug test panel and a panel that specifically includes fentanyl is an important part of program planning. Not every testing device offers the same coverage, which is why reviewing product specifications is essential.
As awareness continues to grow, more employers, treatment providers, and community organizations are evaluating whether fentanyl screening should be included as part of their overall testing strategy.
Fact Friday takeaway:
Fentanyl detection typically requires specific testing coverage. Understanding what your panel includes helps ensure your program aligns with your testing objectives.
Using a credible resource for drug screening supplies helps support consistency and reliability across your program.
